Thermo Fisher Scientific Inc (NYSE: TMO) kicked off on Tuesday, down -2.94% from the previous trading day, before settling in for the closing price of $497.60. Over the past 52 weeks, TMO has traded in a range of $484.27-$627.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.57%. While this was happening, its average annual earnings per share was recorded 6.57%. With a float of $376.61 million, this company’s outstanding shares have now reached $380.77 million.
The extent of productivity of a business whose workforce counts for 125000 workers is very important to gauge. In terms of profitability, gross margin is 41.49%, operating margin of 17.1%, and the pretax margin is 16.41%.
Thermo Fisher Scientific Inc (TMO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Thermo Fisher Scientific Inc is 0.17%, while institutional ownership is 91.45%. The most recent insider transaction that took place on Mar 10 ’25, was worth 2,010,537. In this transaction SVP and General Counsel of this company sold 3,775 shares at a rate of $532.52, taking the stock ownership to the 10,816 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Officer proposed sale 3,776 for $532.45, making the entire transaction worth $2,010,537.
Thermo Fisher Scientific Inc (TMO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.81% during the next five years compared to 12.52% growth over the previous five years of trading.
Thermo Fisher Scientific Inc (NYSE: TMO) Trading Performance Indicators
Take a look at Thermo Fisher Scientific Inc’s (TMO) current performance indicators. Last quarter, stock had a quick ratio of 1.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.25. Likewise, its price to free cash flow for the trailing twelve months is 25.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 16.52, a number that is poised to hit 5.11 in the next quarter and is forecasted to reach 25.73 in one year’s time.
Technical Analysis of Thermo Fisher Scientific Inc (TMO)
The latest stats from [Thermo Fisher Scientific Inc, TMO] show that its last 5-days average volume of 1.8 million was inferior to 1.93 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 12.66%. Additionally, its Average True Range was 11.74.
During the past 100 days, Thermo Fisher Scientific Inc’s (TMO) raw stochastic average was set at 1.36%, which indicates a significant decrease from 3.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.31% in the past 14 days, which was lower than the 23.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $539.38, while its 200-day Moving Average is $561.20. Now, the first resistance to watch is $492.58. This is followed by the second major resistance level at $502.19. The third major resistance level sits at $507.88. If the price goes on to break the first support level at $477.29, it is likely to go to the next support level at $471.60. The third support level lies at $461.99 if the price breaches the second support level.
Thermo Fisher Scientific Inc (NYSE: TMO) Key Stats
The company with the Market Capitalisation of 182.21 billion has total of 377,261K Shares Outstanding. Its annual sales at the moment are 42,879 M in contrast with the sum of 6,335 M annual income. Company’s last quarter sales were recorded 11,395 M and last quarter income was 1,832 M.
